Profil
Elissa S.
Cote is Chief Corporate Development Officer at Vistagen Therapeutics, Inc. since 2025.
Formerly, Ms. Cote was Vice President-Marketing & External Relations at Histogenics Corp.
Ms. Cote was Senior Vice President-Global Strategic Marketing at Sucampo Pharmaceuticals LLC from 2015 to 2018.
Ms. Cote completed undergraduate studies at Union College (New York).
Aktive Positionen von Elissa Cote
| Unternehmen | Position | Beginn |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Corporate Officer/Principal | 23.06.2025 |
Ehemalige bekannte Positionen von Elissa Cote
| Unternehmen | Position | Ende |
|---|---|---|
| SUCAMPO PHARMACEUTICALS, INC. | Vertrieb & Marketing | 01.02.2018 |
| OCUGEN, INC. | Vertrieb & Marketing | - |
Ausbildung von Elissa Cote
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Histogenics Corp.
Histogenics Corp. BiotechnologyHealth Technology Develops and commercializes regenerative medicine | Health Technology |
Union College (New York)
Union College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
VistaGen Therapeutics, Inc.
VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
















